Am J Transplant, Volume 21, Suppl 3 Archives - Page 24 of 139 - ATC Abstracts

2021 American Transplant Congress
Lung Transplantation After Ex-Vivo Lung Perfusion versus Static Cold Storage: A Single Institution Cost Analysis
S. E. Halpern¹, S. J. Kesseli², S. Au¹, M. K. Krischak¹, D. G. Olaso¹, H. Smith³, G. Tipton², I. Jamieson³, J. C. Haney², J. A. Klapper², M. G. Hartwig²
¹Duke University School of Medicine, Durham, NC, ²Surgery, Duke University Medical Center, Durham, NC, ³Office of Finance, Duke Transplant Center, Durham, NC
*Purpose: Ex-vivo lung perfusion (EVLP) allows for reconditioning of “marginal” lung grafts and extended lung preservation. However, EVLP is costlier than cold storage. We compared…
2021 American Transplant Congress
Review of Outcomes After Diagnosis of Malignancy in Kidney Transplant Patients: Unos Database
H. Patel¹, N. Agrawal¹, R. Gupta¹, P. Geetha², A. Abdul Razzack³, F. Cardarelli¹
¹Transplant Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, ²Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, ³Medicine, Dr. NTR University of Health Sciences, Vijaywada, India
*Purpose: Malignancy is the third major cause of death among transplant recipients. Among the transplant recipients, Patient and kidney transplant outcomes after the diagnosis of…
2021 American Transplant Congress
Regional Impact of Covid-19 on Kidney Transplant in the Southeast
C. Jay¹, B. Sharda¹, R. Helmick², R. Forbes³, V. Casingal⁴, R. Stratta¹
¹Wake Forest Baptist Health, Division of Abdominal Organ Transplantation, Winston-Salem, NC, ²University of Tennessee Health Science Center, James Eason Transplant Institute, Memphis, TN, ³Vanderbilt University Medical Center, Division of Kidney and Pancreas Transplantation, Nashville, TN, ⁴Atrium Health, Division of Transplant Surgery, Charlotte, NC
*Purpose: Despite categorization of kidney transplantation as Tier 3b with guidelines against postponing, the impact of the COVID-19 pandemic has been profound but geographically diverse.…
2021 American Transplant Congress
Increased Deceased Organ Donation Rates Among Racial and Ethnic Minorities: Not Exactly. A UNOS/NHSBT UK Donor Data Analysis Over the Last Five Years
H. Sharma¹, A. Pradeep², A. Ditchfield³, M. Abraham⁴, P. Lominchar⁵, S. Mehra¹, A. Skaro⁴
¹Transplant and Vascular Access Surgery, Royal Liverpool University Hospital, Liverpool, United Kingdom, ²Liver Unit, King's College, London, United Kingdom, ³Transplant and Vascular Access Surgery, Manchester Royal Infirmary, Manchester, United Kingdom, ⁴Transplant Surgery, University Of Western Ontario, London, ON, Canada, ⁵Visceral Surgery, Hospital General Universitario Gregorio Marañon, Madrid, Spain
*Purpose: The recent reports suggest that organ donation from minority population have been increasing. The comparative organ donation data from the minority population reported to…
2021 American Transplant Congress
Quality Improvement Surveillance by Machine Learning
J. D. Perkins¹, E. Clemens², M. Granich³, J. Yeung³, J. Reyes¹
¹Surgery, University of Washington, Seattle, WA, ²Pharmacy, University of Washington, Seattle, WA, ³Center of Clinical Excellence, University of Washington, Seattle, WA
*Purpose: The purpose of this quality study was to compare our newly developed natural language processing (NLP) machine learning surveillance algorithm in detecting the rate…
2021 American Transplant Congress
Human Leukocyte Antigen Mismatches Between Donor-Recipient or Donor-Donor are Not Associated with Adverse Pancreas Outcomes in Pancreas After Kidney Transplant Recipients
S. Parajuli, D. Kaufman, B. Welch, H. Sollinger, D. Mandelbrot, J. Odorico
University of Wisconsin, MADISON, WI
*Purpose: A greater degree of HLA mismatch has been previously associated with inferior graft survival in kidney and pancreas transplantation. Pancreas after kidney (PAK) recipients…
2021 American Transplant Congress
Donor Derived Cell Free DNA Identifies Rejection in Simultaneous Pancreas Kidney Transplant Recipients
M. Williams¹, S. Ghosh², L. L. Jenkins², M. Hertl¹, S. Saltzberg³, V. Peev³, E. Chan¹, E. Hollinger¹, E. Schadde¹, O. Olaitan¹
¹Department of Surgery, Rush University Medical Center, Chicago, IL, ²CareDx, Inc., Brisbane, CA, ³Department of Internal Medicine, Rush University Medical Center, Chicago, IL
*Purpose: Increased level of donor-derived cell-free DNA (dd-cfDNA) has proven to be a sensitive marker for allograft rejection after solid organ transplant, particularly heart and…
2021 American Transplant Congress
Trends in Living Donor Transplantation in USA
N. Kemmer, C. Albers, S. Agrawal, R. Syed, M. Malespin, J. Buggs
Tampa General Hospital, Tampa, FL
*Purpose: Globally, living donation has improved access to organ transplantation and saved the lives of individuals with end-stage kidney disease and end-stage liver disease. In…
2021 American Transplant Congress
Kidney Transplantation in Patients with Prior Coronavirus Disease 2019 (COVID-19)
A. Santeusanio, A. Bhansali, M. Rana, S. Lerner, D. Von Ahrens, O. Sulimani, S. Farouk, F. Tedla, R. Shapiro
Mount Sinai Hospital, New York, NY
*Purpose: We describe short-term outcomes as well as peri- and post-transplant complications in patients with prior coronavirus disease 2019 (COVID-19) who subsequently underwent kidney transplantation.*Methods:…
2021 American Transplant Congress
Bamlanivimab for Covid-19 in Kidney Transplant Patients
M. Y. Jan, S. El-Sayegh, M. S. Yaqub, D. P. Mishler, O. Adebiyi, M. D. Anderson, T. E. Taber, A. Sharfuddin
Nephrology, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Treatment options for patients with COVID 19 have limited efficacy in reducing severity and duration of viral symptoms as well as progression to severe…